|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2008-4-22
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Measurement of carotid intima-media thickness (CIMT) has been validated as a measure of atherosclerosis and as a predictor of future cardiovascular events. Compared with glimepiride, pioglitazone has been shown to slow the progression of atherosclerosis measured by CIMT in patients with type 2 diabetes mellitus.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
22
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2123-30
|
|
pubmed:meshHeading |
pubmed-meshheading:18413496-Aged,
pubmed-meshheading:18413496-Carotid Arteries,
pubmed-meshheading:18413496-Carotid Artery Diseases,
pubmed-meshheading:18413496-Cholesterol, HDL,
pubmed-meshheading:18413496-Diabetes Mellitus, Type 2,
pubmed-meshheading:18413496-Disease Progression,
pubmed-meshheading:18413496-Female,
pubmed-meshheading:18413496-Humans,
pubmed-meshheading:18413496-Hypoglycemic Agents,
pubmed-meshheading:18413496-Male,
pubmed-meshheading:18413496-Middle Aged,
pubmed-meshheading:18413496-Predictive Value of Tests,
pubmed-meshheading:18413496-Risk Factors,
pubmed-meshheading:18413496-Sulfonylurea Compounds,
pubmed-meshheading:18413496-Thiazolidinediones,
pubmed-meshheading:18413496-Tunica Intima,
pubmed-meshheading:18413496-Tunica Media
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
|
|
pubmed:affiliation |
Pritzker School of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|
